acetylphenylalanyl-prolyl-boroarginine has been researched along with pepstatin in 1 studies
Studies (acetylphenylalanyl-prolyl-boroarginine) | Trials (acetylphenylalanyl-prolyl-boroarginine) | Recent Studies (post-2010) (acetylphenylalanyl-prolyl-boroarginine) | Studies (pepstatin) | Trials (pepstatin) | Recent Studies (post-2010) (pepstatin) |
---|---|---|---|---|---|
30 | 0 | 0 | 696 | 0 | 125 |
Protein | Taxonomy | acetylphenylalanyl-prolyl-boroarginine (IC50) | pepstatin (IC50) |
---|---|---|---|
Pepsin A | Sus scrofa (pig) | 0.011 | |
Renin | Homo sapiens (human) | 1.9333 | |
Cathepsin D | Homo sapiens (human) | 0.3597 | |
Procathepsin L | Homo sapiens (human) | 0.8 | |
Cathepsin B | Homo sapiens (human) | 4.26 | |
Candidapepsin-2 | Candida albicans | 0.09 | |
Pepsin A-5 | Homo sapiens (human) | 0.059 | |
Cathepsin E | Homo sapiens (human) | 0.5558 | |
Plasmepsin-1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0009 | |
Plasmepsin-2 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0005 | |
Cathepsin D | Bos taurus (cattle) | 0.0235 | |
Disintegrin and metalloproteinase domain-containing protein 9 | Homo sapiens (human) | 0.0563 | |
Plasmepsin 4 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0003 | |
Cysteine protease | Leishmania donovani | 0.16 | |
Protease | Human immunodeficiency virus 1 | 0.947 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbenante, G; Fairlie, DP; Leung, D | 1 |
1 review(s) available for acetylphenylalanyl-prolyl-boroarginine and pepstatin
Article | Year |
---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |